Axon Enterprise Inc (AXON)

Q4 implies lower adjusted EBITDA margins than achieved in Q3 due to timing of expenses and Dedrone integration costs - ; how confident are you in achieving your 25% margin target for 2025 - , and what measures are you implementing to mitigate further integration costs or unexpected expenses?

With TASER hitting revenue records for six consecutive quarters - , but concerns about the sustainability of this growth emerging - , what specific strategies do you have to ensure TASER remains a major growth driver, and how do you plan to address potential market saturation or increased competition?

Regarding the Dedrone acquisition and its role in your Drone as a First Responder (DFR) program - , how do you plan to expand this opportunity internationally, given the differing use cases and regulations, and what challenges do you anticipate in scaling this business outside the U.S.?

Considering you're on track to deliver your initial $2 billion revenue target for 2025 a full year early - , are there risks of overextending resources or facing capacity constraints, and how are you ensuring operational scalability to maintain service quality and customer satisfaction?

With the importance of FedRAMP high status in winning U.S. federal contracts - , how are you leveraging this advantage to significantly grow your federal business, and are there challenges or limitations in this sector compared to state and local markets that might impact your growth expectations?